Topics
Glioblastoma | Treatment | Targeted therapy | Regorafenib
Home > Publications > Topics > Glioblastoma > Treatment > Targeted therapy > Regorafenib
Mongiardi MP, Pallini R, D'Alessandris QG, Levi A, Falchetti
ML.
Regorafenib and glioblastoma: a
literature review of preclinical studies, molecular mechanisms and
clinical effectiveness.
Expert
Rev Mol Med. 2024 Apr 2;26:e5. doi:
10.1017/erm.2024.8. PMID:
38563164. Review. ˍ
Berro A, Assi A, Farhat M, Hatoum L, Saad JP, Mohanna R, Bechara
AMA, Prince G, Hachem MCR, Zalaquett Z, Kourie HR.
Unlocking
Hope: Anti-VEGFR inhibitors and their potential in glioblastoma
treatment.
Crit
Rev Oncol Hematol. 2024 Apr 25:104365. doi:
10.1016/j.critrevonc.2024.104365. PMID:
38677355. Review˰
ˍ